Sunday, Sept. 7

7:00 a.m.- 8:15 a.m.
Meet-the-Experts

Applicability of Lessons Learned from Knowledge of the Molecular Epidemiology of Carbapenemase-Producing Enterobacteriaceae
MALDI-ToF Mass Spectrometry and Laboratory Workflow
Infection Control Issues in Children's Hospitals
Pediatric Bone Infections: From Pathogenesis to Practice Guidelines
Update on the Treatment of HCV/HIV Co-Infection
Latest Issues in Prevention of Surgical Site Infections
Antifungal Prophylaxis Versus Biomarker Driven Approach: What Should We Be Doing?
CMV: Friend or Foe?
The Ongoing Battle with DNA Viruses in Transplantation

 

8:30 a.m. - 10:30 a.m.
ID Quiz

 

8:30 a.m. - 10:30 a.m.
Interactive Symposium

Fungal Resistance

 

8:30 a.m. - 10:30 a.m.
Symposia

Developing New Antibacterial Agents That Are More Robust: Can Pharmacologic Strategies Prevent the Emergence of Resistance?
Infectious Diseases, Inflammation, and Sepsis: Help the Host!
Network Initiatives for Surveillance and/or Molecular Tracing of Antimicrobial Resistant Bacteria: Impact of Data in Designing Public Health Improvements and Priorities
Quit Stalling! New Information on the Interaction of Antibiotics with the Bacterial Ribosome
Update on Global Infections
The A to Z of Streptococci
The Microbiome in Transplantation: Infection and Rejection

 

8:30 a.m. - 11:00 a.m.
Slide Sessions

Deciphering Polymyxin Resistance
Antiretroviral Therapy: New Drugs, New Strategies
Neonatal Infections and the Case for Maternal Immunization
Diagnosis and Treatment of Complicated Infections
Epidemiology of Multidrug-Resistant Organisms
Hepatitis and CMV: New and Noteworthy

 

11:00 a.m. - 1:00 p.m.
Poster Sessions

Clinical Pharmacology of Anti-Infective Agents in Clinical Development
Pharmacokinetics/Pharmacodynamics of Antifungal Agents
Pharmacokinetics/Pharmacodynamics of Special Patient Populations: Obesity, Critically Ill, and Pediatrics
Antibiotic Resistance in Animals and Food
Ceftaroline and New Beta-Lactam/Beta-Lactamase Inhibitor Combinations: The Real Efficacy
Epidemiological Surveys: Resistance to Broad-Spectrum Cephalosporins among Gram-Negatives
MRSA: Epidemiology and Updates
Susceptibility to Newer Anti Gram-Positive Molecules
Susceptibility/Resistance to Tigecycline: Latest News
Antimicrobial Susceptibility Testing Methods and Interpretation for Gram-Negative Pathogens
Antimicrobial Susceptibility Testing Methods and Interpretation for Gram-Positive Pathogens
Antimicrobial Susceptibility Testing—Antibiotic Combinations
Gram-Negative Resistance Detection
Methods for the Detection of Bacteremia and the Impact on Clinical Care
Surveillance for and Epidemiology of Resistant Gram-Positive Cocci
Animal Models, Sepsis, Skin and Soft Tissue Infections, Endocarditis and Endovascular Infections
Beta-Lactamase Inhibitors: Defeating Bacterial Defenses
Glycopeptides and Conjugates
Targeting Gram-Positive Pathogens
Pediatric Epidemiology
Antiretrovirals: New Drugs, Efficacy, Safety, and Pharmacokinetics
Gram-Negative Infections: Treatment
Infections Caused by Carbapenem-Resistant Gram-Negatives
Infections Caused by ESBL-Producing Gram-Negative Organisms
Peusdomonas Infections
Resistant Gram-Negative Infections: Epidemiology
Clinical Studies in Mycobacterial Infections (TB and Non-TB)
Clinical Studies in Urinary Tract Infections
Fungal Epidemiology
Neglected Tropical Diseases, Parasitic Helminthic and Protozoan Infections, Malaria, Global Health, and Travel Medicine

 

1:30 p.m. - 2:30 p.m.
Cubist-ICAAC Award and Lecture

 

3:00 p.m. - 5:00 p.m.
Symposia

Streptococcus pneumoniae: What's New and Cool
Antimicrobial Resistance Threats: Trends in Selected Community- and Healthcare-Associated Bacterial Pathogens
Resistance in the Community: What Kind of Problems?
Anaerobes: Not Your Orphan Organisms Any Longer
Filling the Pipeline: Academic Drug Discovery
Newer Laboratory Methods: Facilitating Detection of Resistance, Public Health, and Infection Prevention
Diagnosis of Latent TB Infection (LTBI)
Management of Endocarditis: An Update
Deworming the World's Children
Fungal Infections in Transplantation: Bench to Bedside
The Changing Face of Coronaviruses


Interactive Symposia

Nephrotoxicity of Colistin and Polymyxin B: Are They Peas in a Pod?
Pediatric Infectious Diseases Interactive Cases

 

3:00 p.m. - 5:30 p.m.
Slide Sessions

Pharmacokinetic/Pharmacodynamic Considerations in the Development of New Anti-Infective Agents
New Insights into the Beta-Lactamase/Beta-Lactamase Inhibitors Combinations
Challenging Co-Morbidities in HIV
Fungal Epidemiology in the Clinics

 

5:45 p.m. - 7:45 p.m.
Special Interest Symposium 

Recent Advances on Antimicrobial Chemotherapy
Developed in cooperation with the Global Chinese Association of Clinical Microbiology and Infectious Diseases (GCACMID)